Hologic (HOLX +2.2%) moves up after Morgan Stanley raises the stock to Overweight on valuation,...
Hologic (HOLX +2.2%) moves up after Morgan Stanley raises the stock to Overweight on valuation, citing an improved outlook for its Tomosynthesis mammography technology.
From other sites
at Zacks.com (Thu, 9:51AM)
at Nasdaq.com (Mar 16, 2015)
at Zacks.com (Mar 6, 2015)
at Nasdaq.com (Jan 12, 2015)
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs